Choosing leukotriene inhibitors or antihistamines for asthma
Asthma and allergy can produce similar symptoms, including wheezing, cough, nasal congestion and difficulty sleeping. The underlying causes are different, however. Asthma involves inflammation and narrowing of the airways, while allergic rhinitis usually results from an immune response to pollen, dust mites, mould or animal dander.
When deciding how to choose between leukotriene inhibitors and antihistamines, the main question is which symptoms need treatment. A medicine that settles sneezing and itchy eyes may do little for lower-airway inflammation, while an asthma preventer may not relieve a blocked nose or eye irritation.
Most Australian asthma care starts with an inhaled corticosteroid-containing preventer, with additional treatment based on symptoms, triggers and inhaler technique. A leukotriene receptor antagonist may be used as an alternative or add-on medicine, whereas antihistamines mainly manage allergy symptoms outside the lungs.
This guide explains when each option may be appropriate. Individual treatment should be arranged with a GP, respiratory specialist or pharmacist, particularly for children, pregnancy, frequent attacks or other medication use.
How asthma and allergy symptoms differ
Histamine is one of several substances released during an allergic reaction. Antihistamines block its effects around the skin, nose and eyes, reducing sneezing, itching, hives and watery eyes. They do not adequately treat the airway inflammation responsible for most asthma symptoms.
Leukotrienes are different inflammatory chemicals. They can tighten bronchial muscles and increase mucus production, so medicines that block their action may reduce both asthma symptoms and some features of allergic rhinitis. Patients buying through online health stores should still check active ingredients with an Australian pharmacist, especially with imported products.
When leukotriene inhibitors can help
The term leukotriene inhibitors usually refers to leukotriene receptor antagonists, or LTRAs, in Australian prescribing. Montelukast and zafirlukast block the action of leukotrienes and are generally used as preventers. They are not reliever medicines and will not stop an attack already underway.
They are most often considered when asthma remains inadequately controlled with an inhaled corticosteroid, or for particular problems such as exercise-related airway narrowing. Montelukast may also help seasonal nasal symptoms when asthma and hay fever occur together. Any decision to add, replace or withdraw an inhaled medicine belongs with the prescriber.
Where antihistamines have a role
Oral antihistamines such as cetirizine, loratadine and fexofenadine can be useful when sneezing, itchy eyes or hives are the main problems. They should not be relied upon to prevent asthma attacks or to treat breathlessness caused by asthma. Sedating antihistamines can also affect driving, work or study, so a non-sedating option is usually preferable.
For irritated or watery eyes, preservative-free artificial tears may help rinse away irritants without the effects of a systemic medicine. This information on preservative-free artificial tears relates to eye comfort rather than asthma control. People with persistent eye symptoms should discuss whether allergy drops, nasal treatment or another remedy is more suitable.
Weighing side effects and interactions
Montelukast carries warnings about serious neuropsychiatric effects, including agitation, depression, disturbed sleep and suicidal thoughts or behaviour. The risk is uncommon, but a prescriber should review mood and sleep symptoms before treatment starts. Significant changes should be reported promptly, and urgent help is needed if someone develops suicidal thoughts.
Anyone checking medication side effects online should cross-check the information against the Consumer Medicine Information leaflet supplied by a chemist or advice from a clinician. Common issues with LTRAs can include headache or abdominal discomfort, while antihistamines may cause drowsiness or dry mouth. Supplements and non-prescription products also need to be included in an interaction review.
Using Australian guidelines in practice
National Asthma Council Australia and Lung Foundation Australia guidance places inhaled corticosteroid-containing treatment at the centre of asthma prevention for most people. Before adding another medicine, clinicians should check whether the preventer is being taken consistently, whether a spacer is suitable and whether inhaler technique is effective.
Asthma medicines generally require a prescription in Australia, and the Pharmaceutical Benefits Scheme may subsidise some treatments depending on the current listing and eligibility. An online over-the-counter catalogue may help identify an antihistamine’s active ingredient, but a listing does not make it suitable for asthma. Telehealth GPs can provide scripts, although an initial assessment may require an in-person lung-function test and inhaler technique check.
Local triggers and other medicines
Australian conditions can change the treatment picture. Grass pollen may peak during Melbourne’s spring, while the grass-pollen season can extend through spring and early summer in northern New South Wales and southern Queensland. Bushfire smoke is another major trigger in New South Wales and Victoria, making local air-quality alerts such as Air NSW important during severe smoke events.
New symptoms are not always caused by asthma. A reliever such as salbutamol can cause shakiness, and anxiety may resemble breathlessness. Someone taking a weight-loss medicine who notices jitters from weight-loss medication should discuss timing and interactions with a pharmacist rather than changing several medicines at once. Persistent wheeze or breathlessness still needs an asthma review.
When symptoms need prompt medical care
Reliever medicines are for symptom relief, not treatment of the underlying inflammation. Someone needing their reliever more often than every four hours, waking at night because of asthma or frequently using it for prevention should arrange prompt medical review. A written asthma action plan helps explain when to use the reliever and when to seek care.
Severe breathlessness, difficulty speaking full sentences, blue or grey lips, confusion or failure of the reliever to help require emergency assistance in Australia. Call 000. For non-emergency advice, Asthma Australia’s helpline is available on 1800 432 737, while a local GP can review control, triggers, inhaler technique and the need for a referral.
Book a GP review before changing treatment, and take the medication list, inhaler, spacer and any symptom notes to the appointment. Ask specifically whether the problem is asthma inflammation, allergic rhinitis, a medicine side effect or poor symptom control, then agree on a written plan that covers daily prevention, reliever use and emergency steps.